|
🐜
|
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
22 auth.
Sandra D’Alfonso,
N. Barizzone,
Mara Giordano,
A. Chiocchetti,
Corrado Magnani,
L. Castelli,
M. Indelicato,
F. Giacopelli,
M. Marchini,
Raffaella Scorza,
...
Maria Giovanna Danieli,
M. Cappelli,
S. Migliaresi,
B. Bigliardo,
M. Sabbadini,
E. Baldissera,
Mauro Galeazzi,
G. Sebastiani,
G. Minisola,
Roberto Ravazzolo,
Umberto Dianzani,
P. Momigliano-Richiardi
|
6 |
2005 |
6
🐜
|
|
🐜
|
Proteasomes are a target of the anti-tumour drug vinblastine.
11 auth.
Marco Piccinini,
Ornella Tazartes,
Caterina Mezzatesta,
E. Ricotti,
Stefano Bedino,
F. Grosso,
...
Umberto Dianzani,
Pier-Angelo Tovo,
Michael Mostert,
A. Musso,
M. T. Rinaudo
|
4 |
2001 |
4
🐜
|
|
🐜
|
ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
12 auth.
L. Aragoneses‐Fenoll,
María Montes-Casado,
G. Ojeda,
Yenny Y. Acosta,
J. Herranz,
S. Martínez,
...
C. Blanco-Aparicio,
Gabriel Criado,
J. Pastor,
Umberto Dianzani,
P. Portolés,
J. Rojo
|
4 |
2016 |
4
🐜
|
|
🐬
|
Suppression of CD4+ T Lymphocyte Activation in Vitro and Experimental Encephalomyelitis in Vivo by the Phosphatidyl Inositol 3-Kinase Inhibitor PIK-75
Yenny Y. Acosta,
María Montes-Casado,
L. Aragoneses‐Fenoll,
Umberto Dianzani,
P. Portolés,
José M. Rojo
|
3 |
2014 |
3
🐬
|
